transplantation Lung transplantation
clinical assessment of lungs
lung function
EVLP technique
new lungs
quality of lungs
Clinical outcomes
lung perfusion
standard lungs
transplanted lungs
Exploitation of EVLP
clinical program
clinical relevance
clinical study
number of lung transplantations
XVIVO
utilization rate of donated lungs
leading clinical scientists
selected patients
end-stage lung diseases
ill patients
new biomarkers
revenue increase
phase
collaboration
optimal biomarkers
donated organs
project
subjective assessment methods
clinicians
addition
customer need
therapeutic option
validated tools
objective metrics
waiting lists
validity
solutions
s product portfolio
broader range of hospitals
company
uncertainty
identified biomarker companies
main reason
impact
systems
Centers
true potential
access
device
MEUR
year
order
market
income